The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 2, 2002, Pages 828-833

  Fossa, Anthony A ^a,b   Depasquale, Michael J ^a   Raunig, David L ^a   Avery, Michael J ^a   Leishman, Derek J ^a,b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; ANTIARRHYTHMIC AGENT; CISAPRIDE; POTASSIUM CHANNEL BLOCKING AGENT; TERFENADINE; TERODILINE; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DRUG BINDING; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HEART BEAT; HEART CONDUCTION; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; MALE; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; QT INTERVAL; RR INTERVAL;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BUTYLAMINES; CISAPRIDE; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HEART RATE; LONG QT SYNDROME; MALE; PIPERIDINES; PYRIDINES; TERFENADINE; VERAPAMIL;

EID: 0036073975     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.035220     Document Type: Article

References (32)

1. Alteration in calcium handling in cardiac hypertrophy and heart failure
2. An analysis of the time-relations of electrocardiograms
3. Influence of lignocaine on plasma protein binding and pharmacokinetics of verapamil in dogs
4. Torsades de pointes ventricular tachycardia and terodiline
5. Pharmacokinetic and pharmacodynamic effect of high-dose continuous intravenous verapamil infusion: Clinical experience in the intensive care unit
6. Blockade of cardiac potassium and other channels by antihistamines
7. EKG systolic duration in normal subjects and heart disease patients
8. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias
9. The canine Purkinje fiber: An in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis
10. Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis
11. Pharmacokinetics of terodiline and a major metabolite in dogs with a correlation to a pharmacodynamic effect
12. Electrical activity from the sinus region in conscious dogs
13. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications report on a policy conference of the European Society of Cardiology
14. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences
15. + current by therapeutic concentrations of the antispasmodic agent terodiline
16. Molecular basis of transient outward potassium current down-regulation in human heart failure: A decrease in Kv4.3mRNA correlates with a reduction in current density
17. Dynamic analysis of dofetilide-induced changes in ventricular repolarization
18. Comparison of the calcium-antagonistic effects of terodiline, nifedipine and verapamil
19. Intravenous verapamil kinetics in rats: Marked arteriovenous concentration difference and comparison with humans
20. QT corrected for heart rate and relation between QT and RR intervals in Beagle dogs
21. Terfenadine - An updated review of its pharmacological properties and therapeutic efficacy
22. + channels in guinea pig ventricular myocytes
23. Once a day verapamil in essential hypertension
24. Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability
25. Statistical analysis of QT interval as a function of changes in RR interval in the conscious dog
26. I-receptor antagonists astemizole and terfenadine compare with chlorpheniramine and pyrilamine
27. Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence
28. The influence of cisapride and clarithromycin on QT intervals in healthy volunteers
29. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb
30. Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog
31. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels